Nominal Korean-made drugs may not be granted any longer.

Published: 2006-08-16 07:00:00

Updated: 2006-08-16 07:00:00

The KFDA announced on Aug. 9 that the KFDA would not grant it as a Korean-made drug when a drug maker imported finished bulk drugs simply to pack locally according to the revised Working Rules of the Pharmaceutical Affairs Act.

Article 71 (drug descriptions and labelling), paragraph 5 of the W...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK